<p><img src="https://imageproxy.pbkrs.com/https://www.pharmexec.com/_next/image/query-cT03NSZ1cmw9aHR0cHM6Ly9jZG4uc2FuaXR5LmlvL2ltYWdlcy8wdnY4bW9jNi9waGFybWV4ZWMvOTk4MzAzYTdkYzkwZGMxNGU4MDI2ODYzZjU4MTUzNDZhNTU2MWUwNC0xMjgweDcyMC5wbmc_Zml0PWNyb3AmYXV0bz1mb3JtYXQmdz0zODQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.pharmexec.com/_next/image/query-cT03NSZ1cmw9aHR0cHM6Ly9jZG4uc2FuaXR5LmlvL2ltYWdlcy8wdnY4bW9jNi9waGFybWV4ZWMvOTk4MzAzYTdkYzkwZGMxNGU4MDI2ODYzZjU4MTUzNDZhNTU2MWUwNC0xMjgweDcyMC5wbmc_Zml0PWNyb3AmYXV0bz1mb3JtYXQmdz0zODQw"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.sanity.io/images/0vv8moc6/pharmexec/998303a7dc90dc14e8026863f5815346a5561e04-1280x720.png/query-YXV0bz1mb3JtYXQmZml0PWNyb3A?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.sanity.io/images/0vv8moc6/pharmexec/998303a7dc90dc14e8026863f5815346a5561e04-1280x720.png/query-YXV0bz1mb3JtYXQmZml0PWNyb3A"/></p>
<p>克里西·泰根是賽諾菲糖尿病宣傳活動的新面孔。該教育活動名為 “篩查 1 型糖尿病”，旨在提供有關篩查該疾病重要性的信息。賽諾菲表示，血液檢測可以在症狀出現之前識別出這種疾病。</p>
<p>泰根在她的兒子邁爾斯僅 6 歲時被診斷出患有該疾病後加入了這一活動。她表示，邁爾斯曾短暫住院，她希望通過分享作為母親的經歷，能夠幫助其他家庭避免這種情況。</p>
<p>在一份新聞稿中，泰根説：“在 2024 年之前，我們家對 1 型糖尿病一無所知——我説的完全是 ‘一無所知’。當邁爾斯首次被診斷時，我們感到困惑和害怕。邁爾斯是一個戰士——1 型糖尿病的戰士——我們每天都在一起學習如何幫助他管理這種疾病，但我毫不懷疑，提前知道這一點會對邁爾斯、我和我們整個家庭產生積極的影響。我希望每個人都能聽到我説的話：保持主動，今天就和你的醫生談談為自己或你所愛的人篩查 1 型糖尿病！”</p>
<p>在同一份新聞稿中，賽諾菲美國 1 型糖尿病自免疫業務負責人納迪亞·豐坦補充道：“許多人仍然在嚴重併發症出現時才發現自己被診斷為 1 型糖尿病，這是不可接受的。我們很高興能與克里西·泰根合作開展 ‘篩查 1 型糖尿病’ 運動，並相信她的故事會與家庭產生強烈共鳴，並強調早期風險檢測的重要性。”</p>
<p>這是賽諾菲改善患者狀況的最新努力。去年 10 月，該公司宣佈將向霍華德大學醫學院、梅哈里醫學院和摩爾豪斯醫學院捐贈 1800 萬美元，以實現改善臨牀試驗多樣性的目標。</p>
<p>在當時發佈的新聞稿中，賽諾菲高級副總裁兼全球臨牀試驗與運營負責人利昂內爾·巴斯克爾表示：“在賽諾菲，我們的使命是追求科學的奇蹟，以改善人們的生活，這意味着所有人的生活，無論他們的種族或民族如何。通過與這三所享有盛譽的歷史黑人大學醫學院合作，我們希望為長期在醫療保健中被代表不足的社區開闢新的途徑。增加多樣性和包容性對為各類背景的人研發藥物和疫苗至關重要。”</p>
<p>摩爾豪斯醫學院院長兼首席執行官瓦萊麗·蒙哥馬利·賴斯博士補充道：“摩爾豪斯醫學院對賽諾菲在我們臨牀研究多樣性卓越中心的投資深表感謝。我們期待着建立穩健的合作關係，以增加臨牀研究中的多樣性，併為研究人員開發更多的機會，從而實現更大的健康公平。臨牀研究中的更多多樣性將確保傳統上服務不足的人羣獲得最新的前沿治療創新。”</p>
<h2>來源</h2>
<ol>
<li>克里西·泰根 - 作者、企業家、1 型糖尿病小兒子的母親 - 加入賽諾菲的 “篩查 1 型糖尿病” 運動。<em>賽諾菲</em>。2025 年 4 月 15 日。https://www.prnewswire.com/news-releases/chrissy-teigen--author-entrepreneur-mom-to-young-son-with-type-1-diabetes--joins-sanofis-screen-for-type-1-movement-302426703.html</li>
<li>賽諾菲承諾向霍華德大學醫學院、梅哈里醫學院和摩爾豪斯醫學院捐贈 1800 萬美元，以增加臨牀研究中的多樣性。<em>賽諾菲</em>。2024 年 10 月 16 日。訪問日期：2025 年 4 月 18 日。https://www.prnewswire.com/news-releases/sanofi-commits-18-million-to-howard-university-college-of-medicine-meharry-medical-college-and-morehouse-school-of-medicine-to-increase-diversity-in-clinical-studies-302276979.html</li>
</ol>

賽諾菲

<p>克里西·泰根已成為賽諾菲糖尿病宣傳活動 “篩查 1 型糖尿病” 的代言人，旨在促進對 1 型糖尿病的早期篩查。泰根的參與源於她 6 歲兒子邁爾斯的診斷，突顯了主動健康措施的必要性。賽諾菲的納迪亞·豐坦強調了早期發現的重要性，以防止嚴重併發症。此外，賽諾菲承諾投入 1800 萬美元，通過與歷史悠久的黑人醫學院合作，增強臨牀試驗的多樣性，旨在改善醫療保健的代表性和公平性</p>

<p><img src="https://imageproxy.pbkrs.com/https://www.pharmexec.com/_next/image/query-cT03NSZ1cmw9aHR0cHM6Ly9jZG4uc2FuaXR5LmlvL2ltYWdlcy8wdnY4bW9jNi9waGFybWV4ZWMvOTk4MzAzYTdkYzkwZGMxNGU4MDI2ODYzZjU4MTUzNDZhNTU2MWUwNC0xMjgweDcyMC5wbmc_Zml0PWNyb3AmYXV0bz1mb3JtYXQmdz0zODQw" alt="" original-src="https://www.pharmexec.com/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fpharmexec%2F998303a7dc90dc14e8026863f5815346a5561e04-1280x720.png%3Ffit%3Dcrop%26auto%3Dformat&amp;w=3840&amp;q=75"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.sanity.io/images/0vv8moc6/pharmexec/998303a7dc90dc14e8026863f5815346a5561e04-1280x720.png/query-YXV0bz1mb3JtYXQmZml0PWNyb3A" alt="" original-src="https://cdn.sanity.io/images/0vv8moc6/pharmexec/998303a7dc90dc14e8026863f5815346a5561e04-1280x720.png?fit=crop&amp;auto=format"/></p>
<p>Chrissy Teigin is the new face of Sanofi’s diabetes campaign.1 The educational campaign is called Screen for Type 1, and it is focused on providing information about the importance of screening for the disease. According to Sanofi, blood tests can identify the condition before symptoms have begun to present themselves.</p>
<div class="lb-trans"><p>克里西·泰根是賽諾菲糖尿病宣傳活動的新面孔。該教育活動名為 “篩查 1 型糖尿病”，旨在提供有關篩查該疾病重要性的信息。賽諾菲表示，血液檢測可以在症狀出現之前識別出這種疾病。</p>
</div><p>Teigen joined the campaign after her son Miles was diagnosed with the disease at just 6 years old. According to her, Miles briefly ended up in the hospital, and she hopes that by sharing her experiences as a mother that she can help other families avoid this.</p>
<div class="lb-trans"><p>泰根在她的兒子邁爾斯僅 6 歲時被診斷出患有該疾病後加入了這一活動。她表示，邁爾斯曾短暫住院，她希望通過分享作為母親的經歷，能夠幫助其他家庭避免這種情況。</p>
</div><p>In a press release, Teigen said, “Our family knew nothing about type 1 diabetes prior to 2024–and when I say nothing, I mean absolutely nothing. We were confused and scared when Miles was first diagnosed. Miles is a warrior–a type 1 diabetes warrior–and we are learning together every day how to help him manage this disease, but there is no doubt in my mind that knowing in advance would have made a positive impact for Miles, me, and our entire family. I want everyone to hear me when I say: stay proactive and talk to your doctor about getting yourself or your loved ones screened for type 1 diabetes today!&#34;</p>
<div class="lb-trans"><p>在一份新聞稿中，泰根説：“在 2024 年之前，我們家對 1 型糖尿病一無所知——我説的完全是 ‘一無所知’。當邁爾斯首次被診斷時，我們感到困惑和害怕。邁爾斯是一個戰士——1 型糖尿病的戰士——我們每天都在一起學習如何幫助他管理這種疾病，但我毫不懷疑，提前知道這一點會對邁爾斯、我和我們整個家庭產生積極的影響。我希望每個人都能聽到我説的話：保持主動，今天就和你的醫生談談為自己或你所愛的人篩查 1 型糖尿病！”</p>
</div><p>In the same press release, Nadia Fontaine, head of US autoimmune type 1 diabetes franchise for Sanofi, added, “It's unacceptable that many people are still finding out about a type 1 diabetes diagnosis only when serious complications arise. We're energized to partner with Chrissy Teigen on the Screen For Type 1 movement and believe her story will strongly resonate with families and underscore the importance of early risk detection.&#34;</p>
<div class="lb-trans"><p>在同一份新聞稿中，賽諾菲美國 1 型糖尿病自免疫業務負責人納迪亞·豐坦補充道：“許多人仍然在嚴重併發症出現時才發現自己被診斷為 1 型糖尿病，這是不可接受的。我們很高興能與克里西·泰根合作開展 ‘篩查 1 型糖尿病’ 運動，並相信她的故事會與家庭產生強烈共鳴，並強調早期風險檢測的重要性。”</p>
</div><p>This is Sanofi’s latest endeavor to improve patient conditions. In October of last year, the company announced that it would be contributing $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine as part of the company’s goal of improving diversity in clinical trials.2</p>
<div class="lb-trans"><p>這是賽諾菲改善患者狀況的最新努力。去年 10 月，該公司宣佈將向霍華德大學醫學院、梅哈里醫學院和摩爾豪斯醫學院捐贈 1800 萬美元，以實現改善臨牀試驗多樣性的目標。</p>
</div><p>In a press release issued at the time, Sanofi’s senior vice president and global head of clinical trials and operations Lionel Bascles said, “At Sanofi, our mission is to chase the miracles of science to improve people's lives, and this means all people's lives, regardless of their race or ethnicity. By partnering with these three esteemed Historically Black College and University medical schools, we hope to facilitate new inroads to communities that have been underrepresented in healthcare for far too long. Increasing diversity and inclusion is essential to the research and development of medicines and vaccines for people of all backgrounds.&#34;</p>
<div class="lb-trans"><p>在當時發佈的新聞稿中，賽諾菲高級副總裁兼全球臨牀試驗與運營負責人利昂內爾·巴斯克爾表示：“在賽諾菲，我們的使命是追求科學的奇蹟，以改善人們的生活，這意味着所有人的生活，無論他們的種族或民族如何。通過與這三所享有盛譽的歷史黑人大學醫學院合作，我們希望為長期在醫療保健中被代表不足的社區開闢新的途徑。增加多樣性和包容性對為各類背景的人研發藥物和疫苗至關重要。”</p>
</div><p>Valerie Montgomery Rice, MD, FACOG, president and CEO of the Morehouse School of Medicine added, “Morehouse School of Medicine is exceptionally grateful to Sanofi for this investment in our clinical study diversity Center of Excellence. We look forward to a robust partnership as we work to increase diversity in clinical studies and develop advanced opportunities for researchers, leading to greater health equity. More diversity in clinical studies will ensure traditionally underserved populations receive the very latest cutting-edge therapeutic innovations.&#34;</p>
<div class="lb-trans"><p>摩爾豪斯醫學院院長兼首席執行官瓦萊麗·蒙哥馬利·賴斯博士補充道：“摩爾豪斯醫學院對賽諾菲在我們臨牀研究多樣性卓越中心的投資深表感謝。我們期待着建立穩健的合作關係，以增加臨牀研究中的多樣性，併為研究人員開發更多的機會，從而實現更大的健康公平。臨牀研究中的更多多樣性將確保傳統上服務不足的人羣獲得最新的前沿治療創新。”</p>
</div><h2>Sources</h2>
<div class="lb-trans"><h2>來源</h2>
</div><ol>
<li>Chrissy Teigen - Author, Entrepreneur, Mom to Young Son with Type 1 Diabetes - Joins Sanofi's Screen For Type 1 Movement. <em>Sanofi</em>. April 15, 2025. https://www.prnewswire.com/news-releases/chrissy-teigen--author-entrepreneur-mom-to-young-son-with-type-1-diabetes--joins-sanofis-screen-for-type-1-movement-302426703.html</li>
<li>Sanofi Commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to Increase Diversity in Clinical Studies. <em>Sanofi</em>. October 16, 2024. Accessed April 18, 2025. https://www.prnewswire.com/news-releases/sanofi-commits-18-million-to-howard-university-college-of-medicine-meharry-medical-college-and-morehouse-school-of-medicine-to-increase-diversity-in-clinical-studies-302276979.html</li>
</ol>
<div class="lb-trans"><ol>
<li>克里西·泰根 - 作者、企業家、1 型糖尿病小兒子的母親 - 加入賽諾菲的 “篩查 1 型糖尿病” 運動。<em>賽諾菲</em>。2025 年 4 月 15 日。https://www.prnewswire.com/news-releases/chrissy-teigen--author-entrepreneur-mom-to-young-son-with-type-1-diabetes--joins-sanofis-screen-for-type-1-movement-302426703.html</li>
<li>賽諾菲承諾向霍華德大學醫學院、梅哈里醫學院和摩爾豪斯醫學院捐贈 1800 萬美元，以增加臨牀研究中的多樣性。<em>賽諾菲</em>。2024 年 10 月 16 日。訪問日期：2025 年 4 月 18 日。https://www.prnewswire.com/news-releases/sanofi-commits-18-million-to-howard-university-college-of-medicine-meharry-medical-college-and-morehouse-school-of-medicine-to-increase-diversity-in-clinical-studies-302276979.html</li>
</ol>
</div>

克里斯蒂·泰根參與賽諾菲的早期糖尿病檢測宣傳活動